Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Dose-Determination Safety, Tolerability, and Activity Study of Inhaled NX1011 in Patients With Pulmonary Arterial Hypertension

NCT00323024 is registered in ClinicalTrials.gov with NITROX, LLC as lead sponsor.

NCT NCT00323024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00323024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Dose-Determination Safety, Tolerability, and Activity Study of Inhaled NX1011 in Patients With Pulmonary Arterial Hypertension
Lead sponsor
NITROX, LLC
Phase
Phase 2
Overall status
Withdrawn
Start date
September 30, 2006
Completion date
May 31, 2007
Enrollment
72
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension